Results 11 to 20 of about 47,941 (305)

Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review

BMC Women's Health, 2020
Background A wide range of drugs have been studied for first trimester medical abortion. Studies evaluating different regimens, including combination mifepristone and misoprostol and misoprostol alone regimens, show varying results related to safety ...
Ferid A. Abubeker, Antonella Lavelanet, Maria I. Rodriguez, Caron Kim   +3 more
doaj   +2 more sources

Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis

Scientific Reports, 2017
The efficacy and safety of misoprostol alone for missed abortion varied with different regimens. To evaluate existing evidence for the medical management of missed abortion using misoprostol, we undertook a comprehensive review and meta-analysis.
Hang-lin Wu, Sheeba Marwah, Pei Wang, Qiu-meng Wang, Xiao-wen Chen   +4 more
doaj   +2 more sources

Effect of extra-amniotic Foley’s catheter and vaginal misoprostol versus vaginal misoprostol alone on cervical ripening and induction of labor in Kenya, a randomized controlled trial

BMC Pregnancy and Childbirth, 2018
Background The safest, most effective and fastest combined approaches to induction of labor is unknown. In an open-label randomized clinical trial we evaluated the efficacy of combination of extra-amniotic Foley’s catheter and vaginal misoprostol ...
Alfred Osoti, Davies Kiprop Kibii, Tito Mario Kual Tong, Innocent Maranga   +3 more
doaj   +2 more sources

Misoprostol and diarrhea [PDF]

Nursing, 1998
Joel Shuster
openalex   +4 more sources

Misoprostol in a topsyturvy world [PDF]

Journal of Medical Ethics, 2001
sir In the January 4 issue of the New England Journal of Medicine three articles appeared on the unapproved use of Misoprostol (Cytotec), which raise an interesting ethical question. The synthetic prostaglandin analogue, Misoprostol, has been successfully used by obstetricians and gynaecologists for a number of years for the induction of a medical ...
D. O. E. Gebhardt
openalex   +5 more sources

Low-dose oral misoprostol for induction of labour.

Cochrane Database of Systematic Reviews, 2021
BACKGROUND Misoprostol given orally is a commonly used labour induction method. Our Cochrane Review is restricted to studies with low-dose misoprostol (initially ≤ 50 µg), as higher doses pose unacceptably high risks of uterine hyperstimulation ...
R. Kerr, Nimisha Kumar, Myfanwy J Williams, Anna Cuthbert, Nasreen B Aflaifel, D. Haas, A. Weeks   +6 more
semanticscholar   +1 more source

Pretreatment With Mifepristone Compared With Misoprostol Alone for Delivery After Fetal Death Between 14 and 28 Weeks of Gestation

Obstetrics and Gynecology, 2021
The sequential use of mifepristone and misoprostol for termination of pregnancy after fetal death between 14 and 28 weeks of gestation reduces time to delivery compared with misoprostol alone.
E. Allanson, Sean Copson, K. Spilsbury, Sonya Criddle, B. Jennings, D. Doherty, Antonia M. Wong, J. Dickinson   +7 more
semanticscholar   +1 more source

Cost‐effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial

BJOG: an International Journal of Obstetrics and Gynaecology, 2021
To assess the cost‐effectiveness of mifepristone and misoprostol (MifeMiso) compared with misoprostol only for the medical management of a missed miscarriage.
C. Okeke Ogwulu, EV Williams, JJ Chu, A. Devall, Leanne Beeson, P. Hardy, V. Cheed, S. Yongzhong, LL Jones, JH La Fontaine Papadopoulos, R. Bender-Atik, J. Brewin, K. Hinshaw, M. Choudhary, A. Ahmed, J. Naftalin, N. Nunes, A. Oliver, F. Izzat, K. Bhatia, I. Hassan, Y. Jeve, J. Hamilton, S. Debs, C. Bottomley, J. Ross, L. Watkins, M. Underwood, Y. Cheong, Cs Kumar, P. Gupta, R. Small, S. Pringle, F. Hodge, A. Shahid, A. Horne, S. Quenby, I. Gallos, A. Coomarasamy, T. Roberts   +39 more
semanticscholar   +1 more source

Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria

BMJ Open, 2020
Objectives This study aimed to assess the safety and effectiveness of self-managed misoprostol abortions obtained outside of the formal health system in Lagos State, Nigeria.
Melissa Stillman, O. Owolabi, A. Fatusi, A. Akinyemi, A. Berry, T. Erinfolami, O. Olagunju, Heini Väisänen, A. Bankole   +8 more
semanticscholar   +1 more source

Misoprostol and teratogenesis in neonates [PDF]

Brazilian Journal of Pharmaceutical Sciences, 2009
This paper is focused in some aspects of maternal exposure to misoprostol during perinatal period, and the abortive and teratogenesis effects on the fetus. The causes of malformations were revised, taking into account chemical, physical and environmental factors as well as the interaction between them.
Scabora da Silva, Mariana Beatriz, Ferreira, Aline de Assis, Habr, Soraya Ferreira, Bernardi, Maria Martha   +3 more
openaire   +6 more sources